Table of contents
Expand All Topics
Calcium pyrophosphate deposition disease
Guidelines
Key sources
The following summarized guidelines for the evaluation and management of calcium pyrophosphate deposition disease are prepared by our editorial team based on guidelines from the European League Against Rheumatism (EULAR 2024,2023,2011), the American College of Rheumatology (ACR 2023), and the American College of Radiology (ACR 2017).
1
2
3
4
5
6
Diagnostic investigations
Diagnostic imaging: as per EULAR 2024 guidelines, obtain conventional radiography and ultrasound (or CT if axial involvement is suspected) for the evaluation of CPPD.
A
Show 3 more
More topics in this section
Screening for chronic infections
Medical management
General principles: as per EULAR 2011 guidelines, offer both nonpharmacological and pharmacological modalities for optimal treatment of patients with CPPD, tailored according to:
clinical features (isolated chondrocalcinosis, acute, chronic calcium pyrophosphate crystal inflammatory arthritis, osteoarthritis with CPPD)
general risk factors (age, comorbidities)
the presence of a predisposing metabolic disorder.
B
Show 3 more
More topics in this section
Management of acute CPP crystal arthritis
Management of chronic CPP crystal arthritis
Management of OA with CCPD
Preventative measures
Routine immunizations: as per ACR 2023 guidelines, consider offering high-dose or adjuvanted influenza vaccination, rather than regular-dose influenza vaccination, in ≥ 65 years old patients with rheumatic or musculoskeletal diseases and in 18-65 years old patients with rheumatic or musculoskeletal diseases on immunosuppressive medications.
C
Show 17 more
More topics in this section
Prophylaxis for P. jirovecii pneumonia